{"DataElement":{"publicId":"6617442","version":"1","preferredName":"Iobenguane Diagnostic Imaging Assessment Finding Bone Lesion Uptake Status","preferredDefinition":"Status of MIBG uptake at bone lesion","longName":"MIBG_BN_LN_UPTAKE_ST","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"6617423","version":"1","preferredName":"Iobenguane Diagnostic Imaging Assessment Finding","preferredDefinition":"A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells._Any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation._The final result of a determination of the value, significance, or extent of._Clinical, laboratory or molecular evidence, or absence of evidence of disease.","longName":"6617405v1.0:6617421v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6617405","version":"1","preferredName":"Iobenguane Diagnostic Imaging","preferredDefinition":"A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells.:Any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation.","longName":"C87757:C16502","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iobenguane","conceptCode":"C87757","definition":"A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnostic Imaging","conceptCode":"C16502","definition":"Any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FAC93EF-0D1C-4D12-E053-F662850A9450","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6617421","version":"1","preferredName":"Assessment Finding","preferredDefinition":"The final result of a determination of the value, significance, or extent of.:Clinical, laboratory or molecular evidence, or absence of evidence of disease.","longName":"C25217:C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FA99603-1633-439B-E053-F662850A4374","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FA99603-1644-439B-E053-F662850A4374","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"PROSVIROVAB","dateModified":"2019-06-11","changeDescription":"Curated for ANBL1821","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6617436","version":"1","preferredName":"Bone Lesion Uptake Status","preferredDefinition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._Lacking in hardness relatively or comparatively._An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function._The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention._The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention._A condition or state at a particular time._A localized pathological or traumatic structural change, damage, deformity, or discontinuity of bone.","longName":"6617436v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Relative MIBG score >/= 1.2","valueDescription":"Iobenguane Relative Greater Than Or Equality One Score","ValueMeaning":{"publicId":"6617437","version":"1","preferredName":"Iobenguane Relative Greater Than Or Equality One Score","longName":"6617437","preferredDefinition":"A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells.: A person related by blood or marriage.: A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: The quality of being the same in quantity or measure or value or status.: The smallest natural number and quantity it denotes: a single entity, unit, or object.: A number or range of numeric values measuring performance, function, quality, or ability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iobenguane","conceptCode":"C87757","definition":"A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Relative","conceptCode":"C21480","definition":"A person related by blood or marriage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Equality","conceptCode":"C61582","definition":"The quality of being the same in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"One","conceptCode":"C66832","definition":"The smallest natural number and quantity it denotes: a single entity, unit, or object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FAC14A2-F5EA-4088-E053-F662850A4340","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FAC14A2-F603-4088-E053-F662850A4340","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","deletedIndicator":"No"},{"value":"New lesion that is MIBG avid","valueDescription":"Iobenguane Avidity New Lesion Identification","ValueMeaning":{"publicId":"6617438","version":"1","preferredName":"Iobenguane Avidity New Lesion Identification","longName":"6617438","preferredDefinition":"A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells.: Strength of binding, usually of a small molecule with multiple binding sites by a larger, particularly the binding of a complex antigen by an antibody.: The identification of a lesion which has not been previously seen or characterized.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iobenguane","conceptCode":"C87757","definition":"A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Avidity","conceptCode":"C16297","definition":"Strength of binding, usually of a small molecule with multiple binding sites by a larger, particularly the binding of a complex antigen by an antibody.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"New Lesion Identification","conceptCode":"C94522","definition":"The identification of a lesion which has not been previously seen or characterized.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FAC14A2-F611-4088-E053-F662850A4340","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FAC14A2-F62A-4088-E053-F662850A4340","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","deletedIndicator":"No"},{"value":"MIBG uptake completely resolved","valueDescription":"Resolution Uptake Iobenguane","ValueMeaning":{"publicId":"6617426","version":"1","preferredName":"Resolution Uptake Iobenguane","longName":"6617426","preferredDefinition":"A means of finding a solution to a problem, or a means of finding agreement or harmony.: The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.: A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Resolution","conceptCode":"C75906","definition":"A means of finding a solution to a problem, or a means of finding agreement or harmony.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Uptake","conceptCode":"C71688","definition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Iobenguane","conceptCode":"C87757","definition":"A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FAD0CC5-2FA2-586A-E053-F662850A77A1","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FAC14A2-F65F-4088-E053-F662850A4340","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","deletedIndicator":"No"},{"value":"50% or greater reduction in MIBG absolute bone score (Relative MIBG bone score greater than or equal to 0.1 to less than or equal to 0.5)","valueDescription":"Absolute Bone Score Percent Unit Fifty Reduced Iobenguane","ValueMeaning":{"publicId":"6617439","version":"1","preferredName":"Absolute Bone Score Percent Unit Fifty Reduced Iobenguane","longName":"6617439","preferredDefinition":"Complete and without restriction or qualification; something that does not depend on anything else; not relative.: Connective tissue that forms the skeletal components of the body.: A number or range of numeric values measuring performance, function, quality, or ability.: A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).: A natural number greater than forty-nine and less than fifty-one and the quantity that it denotes.: Made less in size or amount or degree.: A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Absolute","conceptCode":"C45829","definition":"Complete and without restriction or qualification; something that does not depend on anything else; not relative.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Bone","conceptCode":"C12366","definition":"The structural organ comprised of specialized connective tissue that forms the skeletal components of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Percent Unit","conceptCode":"C48570","definition":"A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Fifty","conceptCode":"C105785","definition":"A natural number greater than forty-nine and less than fifty-one and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Reduced","conceptCode":"C25640","definition":"Made less in size or amount or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Iobenguane","conceptCode":"C87757","definition":"A synthetic, aralkylguanidine analogue of the adrenergic neurotransmitter norepinephrine (NE) and adrenergic neuron blocking agent with potential diagnostic imaging or antineoplastic activity when radiolabeled. Iobenguane, also known as metaiodobenzylguanidine (MIBG), is taken up and accumulates in the granules of adrenal medullary chromaffin cells and in the pre-synaptic granules of adrenergic neurons in a manner almost identical with that of NE. In radiolabeled forms, iobenguane may be used to image or eradicate neuroendocrine tissues and tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FAC14A2-F63C-4088-E053-F662850A4340","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"80DA7E2A-46B6-104B-E053-F662850A7D21","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-02-01","modifiedBy":"ONEDATA","dateModified":"2019-02-01","deletedIndicator":"No"},{"value":"0-50% reduction in number of MIBG avid bone lesions (relative MIBG score 0.5 < 1.2)","valueDescription":"0-50% reduction in number of MIBG avid bone lesions (relative MIBG score 0.5 < 1.2)","ValueMeaning":{"publicId":"7755251","version":"1","preferredName":"0-50% reduction in number of MIBG avid bone lesions (relative MIBG score 0.5 < 1.2)","longName":"7755251","preferredDefinition":"0-50% reduction in number of MIBG avid bone lesions (relative MIBG score 0.5 < 1.2)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C8842473-0731-2603-E053-4EBD850A0689","latestVersionIndicator":"Yes","beginDate":"2021-08-01","endDate":null,"createdBy":"LAMEMIL","dateCreated":"2021-08-01","modifiedBy":"ONEDATA","dateModified":"2021-08-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C8842473-074A-2603-E053-4EBD850A0689","beginDate":"2021-08-01","endDate":null,"createdBy":"LAMEMIL","dateCreated":"2021-08-01","modifiedBy":"ONEDATA","dateModified":"2021-08-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2233241","version":"1","preferredName":"Medical Imaging","preferredDefinition":"Events, people, materials and activities uniquely defined by medical imaging.  ","longName":"MEDICAL IMAGING","context":"CIP","contextVersion":"2.31","origin":"DICOM:Digital Imaging and Communications in Medicine","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F96173D7-A9B4-3CBB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-12","modifiedBy":"SBREXT","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6617394","version":"1","preferredName":"Uptake Bone Lesion Status","preferredDefinition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.:A localized pathological or traumatic structural change, damage, deformity, or discontinuity of bone.:A condition or state at a particular time.","longName":"C71688:C43260:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uptake","conceptCode":"C71688","definition":"The absorption by a tissue of some substance, food material, mineral, etc., and its permanent or temporary retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Bone Lesion","conceptCode":"C43260","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of bone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FA9E12C-8BB6-6710-E053-F662850A0DCB","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FAC14A2-F5CB-4088-E053-F662850A4340","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"LAMEMIL","dateModified":"2021-09-02","changeDescription":"Curated for ANBL1821","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If Yes, specify:","type":"Preferred Question Text","description":"If Yes, specify:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FAD0CC5-304B-586A-E053-F662850A77A1","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-17","modifiedBy":"PROSVIROVAB","dateModified":"2019-06-11","changeDescription":"Curated for ANBL1821","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}